JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259136

Human SLC44A1 (CTL1) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SLC44A1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 79 bp deletion in exon1.

View Alternative Names

CD 92, CD92 antigen, CD92 protein, CDW 92, CDW92 antigen, CHTL 1, CTL1_HUMAN, Choline transporter-like protein 1, RP11 287A8.1, Solute carrier family 44 member 1, slc44a1

1 Images
Sanger Sequencing - Human SLC44A1 (CTL1) knockout HeLa cell lysate (AB259136)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC44A1 (CTL1) knockout HeLa cell lysate (AB259136)

Homozygous : 79 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 79 bp deletion in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259136-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SLC44A1 knockout HeLa cell lysate", "number":"AB259136-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259136-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC44A1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The target SLC44A1 also known as CTL1 is a member of the choline transporter-like family. This protein is essential for transporting choline across cell membranes. As a membrane protein it is involved in the uptake of choline a necessary precursor for the synthesis of phosphatidylcholine and acetylcholine. CTL1 has a molecular mass of approximately 70 kDa. It is expressed in various tissues including the brain liver and kidneys highlighting its importance across multiple biological systems.
Biological function summary

SLC44A1 plays a significant role in the synthesis of membrane phospholipids. It does not act alone; it forms part of a complex system involving other transporter proteins to ensure efficient choline uptake and utilization. By facilitating choline transport CTL1 supports the production of important lipids for cell membrane integrity and neurotransmission contributing to processes important for cellular communication and function.

Pathways

SLC44A1 impacts significant metabolic pathways such as the Kennedy pathway responsible for phosphatidylcholine biosynthesis. Its activity is closely associated with enzymes like choline kinase and phosphocholine cytidylyltransferase which further facilitate phospholipid biosynthesis. This pathway integration highlights its role in maintaining membrane structure and signaling functions.

SLC44A1 has implications in neurological conditions such as Alzheimer’s disease and certain types of cancer. In Alzheimer's impaired choline transport can lead to deficits in acetylcholine a neurotransmitter necessary for memory and learning. Moreover aberrant expression of CTL1 is linked with oncogenic processes in liver cancer. In these cases its interaction with proteins associated with choline metabolism and cellular growth indicates potential mechanisms underlying disease pathogenesis.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com